Oxidative Medicine and Cellular Longevity, 2016 · DOI: 10.1155/2016/7263736 · Published: January 1, 2016
This study investigates the role of HDAC6 in spinal cord injury (SCI). It explores how HDAC6 affects cell damage caused by reduced oxygen supply (hypoxia-ischemia, HI) and oxidative stress. The research shows that inhibiting HDAC6 worsens cell damage after SCI. This is linked to problems with a cellular cleaning process called chaperone-mediated autophagy (CMA), which normally helps cells cope with stress. The study also suggests that HDAC6 influences CMA by modifying a protein called HSP90. This modification is important for CMA to work correctly and protect cells from damage.
HDAC6 could be a potential therapeutic target in acute SCI. Deacetylation of HSP90 by HDAC6 could be harnessed to promote cell survival and functional recovery after SCI.
Strategies aimed at enhancing CMA activity, possibly through HDAC6 modulation, may offer a neuroprotective approach to mitigate secondary damage after SCI.
Targeting HDAC6 to reduce oxidative stress could be beneficial in the management of SCI-induced cellular damage.